Pharmaceutical giant GlaxoSmithKline tapped Sidley Austin partner Dan Troy to join the company as senior vice president and general counsel on Sept. 2.

Troy, a Washington- and New York-based lawyer who is a partner in Sidley’s life sciences practice and appellate litigation groups, was chief counsel of the U.S. Food and Drug Administration from mid-2001 to the end of 2004. At Sidley, he advises pharmaceutical companies and trade associations on FDA and other regulatory matters.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]